Does 'aggressive approach' equal higher cost?
Forwand
S A
SA
D002170:Canada; D003362:Cost-Benefit Analysis; D006801:Humans; D009203:Myocardial Infarction / Q000191:economics* / Q000628:therapy*; D014481:United States